OCUGEN INC (OCGN:NASDAQ)
$1.77 -0.08 (-4.3243%)
Analysed OCUGEN INC (OCGN:NASDAQ) News Sources
OCU410’s Phase 2 Gene‑Agnostic Results in Dry AMD Might Change The Case For Investing In Ocugen (OCGN)
21-04-2026
yahoo.com
MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock?
20-04-2026
yahoo.com
Evaluating Ocugen (OCGN) After Recent Share Price Swings And Gene Therapy Progress
05-04-2026
yahoo.com
Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?
03-04-2026
yahoo.com
OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study
02-04-2026
yahoo.com
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?
01-04-2026
yahoo.com
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
01-04-2026
yahoo.com
Ocugen (OCGN) Reveals OCU410 Clinical Trial Data
31-03-2026
yahoo.com
How The Ocugen (OCGN) Narrative Is Shifting With Retinal Gene Therapy Data And New Valuations
29-03-2026
yahoo.com
Ocugen Inc. (OCGN): One of the Popular Penny Stocks on Robinhood
27-03-2026
yahoo.com
What is the current price of OCUGEN INC (OCGN:NASDAQ)?
The current price of OCUGEN INC (OCGN:NASDAQ) is $1.77.
OCUGEN INC (OCGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of OCUGEN INC (OCGN:NASDAQ) since the previous trading day is $-0.08.
OCUGEN INC (OCGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of OCUGEN INC (OCGN:NASDAQ) since the previous trading day is -4.3243%.
What is the most recent average sentiment score for OCUGEN INC (OCGN:NASDAQ)?
The most recent average sentiment score for OCUGEN INC (OCGN:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for OCUGEN INC (OCGN:NASDAQ)?
The most recent sentiment for OCUGEN INC (OCGN:NASDAQ) is .
SEC-8K** Filing Available For OCUGEN INC (OCGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.